In Virtual Reality News
December 9, 2022 – AppliedVR, a supplier of immersive therapeutics advancing a novel, virtual reality- (VR) based attack to medicine, has this week announced a declaration with the US Department of Veterans Affairs (VA) to supply its FDA-authorized RelieVRx (formerly EaseVRx) solution to prime Veterans impacted by chronic little backmost symptom (CLBP). AppliedVR was awarded the declaration with the VHA Innovation Ecosystem, a part of the VA that discovers, evaluates, and spreads mission-driven innovations that beforehand attraction transportation for Veterans.
The Veterans Health Administration (VHA) provides attraction to much than 9 cardinal Veterans crossed the US, making it the largest integrated healthcare strategy successful the country. According to AppliedVR, much than 50 percent of Veterans receiving attraction astatine VHA facilities crossed the state are affected by chronic pain. AppliedVR noted that it shares a communal imaginativeness with the VHA Innovation Ecosystem to alteration chronic symptom attraction for US Veterans by enabling much entree to non-pharmacological, noninvasive attraction options specified arsenic virtual world (VR).
Through the associated effort, healthcare providers astatine 18 VA facilities volition person the quality to prescribe the RelieVRx programme to Veterans for usage successful their homes. RelieVRx is an FDA-authorized in-home immersive VR symptom attraction indicated arsenic adjunctive attraction for CLBP. The eight-week programme has been clinically demonstrated to alteration symptom severity and symptom interference successful the lives of radical experiencing CLBP. In a recent objective proceedings follow-up study, the RelieVRx strategy besides was shown to present durable effects six months aft treatment, according to AppliedVR.
“Chronic symptom is challenging to treat—historically, pharmacological interventions similar opioids and NSAIDS, oregon invasive procedures similar injections oregon surgeries person failed to supply alleviation for excessively galore patients, leaving them a bleak outlook. Current guidelines telephone for integrated symptom treatment, and immersive therapeutics similar RelieVRx supply multidimensional therapy successful a single, easy-to-use device. Our evidence-based immersive therapeutics tin assistance Veterans negociate their chronic little backmost symptom by addressing the biopsychosocial aspects of the condition,” said Matthew Stoudt, CEO and co-founder of AppliedVR. “Working with the VHA Innovation Ecosystem represents 1 of the highest honors for our company, due to the fact that US Veterans are heroes, and they merit the world’s champion healthcare that includes the astir precocious technology-driven solutions.”
This week’s announcement marks the latest collaboration betwixt AppliedVR and the VHA Innovation Ecosystem. The 2 organizations previously collaborated to present VR-based solutions that could comfortableness Veterans successful hospice (palliative care) and assistance amended the prime of beingness of Veterans experiencing wide chronic pain, accent and anxiousness successful a assortment of healthcare settings.
AppliedVR did not disclose the magnitude awarded for the VHA Innovation Ecosystem declaration successful its announcement. However, astatine the extremity of September this year, the institution was awarded a USD $500,000 declaration for the proviso of aesculapian and surgical instruments, instrumentality and supplies. Auganix has reached retired to the institution for clarification.
For much accusation connected AppliedVR and its VR-based immersive therapeutics solutions, delight sojourn the company’s website.
Image credit: AppliedVR
Sam Sprigg
Sam is the Founder and Managing Editor of Auganix. With a inheritance successful probe and study writing, helium has been covering XR manufacture quality for the past 5 years.